John Kennedy lambasts GOP for no action on lowering drug prices: ‘We took our shot and we missed’

Published Updated



Sen. John Kennedy (R-LA) lambasted Republicans on Tuesday for being sluggish in passing bipartisan legislation to lower prescription drug prices during the first two years of the Trump presidency.

Kennedy criticized his party’s leadership on the issue of reigning in pharmacy benefits managers, or PBMs, and other middlemen in the drug industry during a Senate Judiciary Committee hearing on how competition and transparency would put downward pressure on prices.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.